Viatris
Search results
4 days ago · Our broad portfolio of approximately 280+ generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets.
Together, we can do more to improve health. That’s a powerful reason to come to work. In addition to being guided by a deep sense of purpose, we’re also focused on rapidly growing our capabilities, our product portfolios and our people – all to increase the number of lives we can touch.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey . [2]
We make healthy possible. | Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines.
Since 2008, we’ve been producing medicines for the U.S. market – a global leader and the gold standard in pharmaceutical quality. Today we’re bringing that same Amneal quality commitment to India patients and families.
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a U.S.-based fully integrated global essential medicines company powered by a robust generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets including India.
Get the latest Amneal Pharmaceuticals Inc (AMRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Jun 28, 2024 · Amneal is a global, diversified pharmaceutical company that provides access to high-quality, affordable, and essential medicines. Press Releases Stock Information
We produce essential medicines. Our broad portfolio is the foundation from which we make healthy possible. In the US, our portfolio of more than 280 medicines provides patients with more affordable access to quality medicines.
